MEGOLA, INC / ACORDY SA (OTC Pink: MGON) COMPLETES RTO (REVERSE TAKEOVER MERGER)

Laguna Hills, California, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Publicly-held Megola, Inc. (OTC Pink: MGON) is pleased to announce the Reverse Take-Over “RTO” of Megola, Inc. and Acordy SA is complete. Acordy SA, formed in 2014 and domiciled in the city of Malaga, Spain, has completed the acquisition of Megola, Inc (MGON) a company registered in the state of Nevada. Acordy President Francisco Baez states: “In the next few weeks we will begin the process of merging Acordy with Megola and Acordy will be the surviving company. We are working with our U.S. attorneys and accountants so as to make the merger as smooth as possible. Going forward, we will be implementing plans with the intent to maximize shareholder value 1) expanding our current products offerings and 2) by leveraging our existing business infrastructure to commercialize CBD products in the next three months. While initially we will be trading on the Pinksheets, we plan on moving up to OTCQB or OTCQX within the next 6-12 months. There is much work to be done, but the first steps have been completed”. John Stippick, former CEO of Megola states, “I am glad to be turning control of Megola to the Acordy team as they are an established company in Europe with impressive financials, an established history, and great plans for the shareholders.”

Management also wants to notify all shareholders and persons of interest to visit for updates and notifications of the company’s original programs and directives.

About Acordy SA.

Acordy S.A. is currently a privately owned Spanish company that was formed in 2014. Acordy has been primarily involved in the production and distribution of food items from Spain with a concentration in olive oils and wines from the Iberian Peninsula. Acordy is also involved with commercial horse breeding. The company is currently planning to become involved in the production and distribution of medical marijuana products and already has the necessary infrastructure in place to commence commercializing CBD products in the next three months.

###

Sections of this press release contain forward looking statements that reflect management’s best judgement based on factors currently known but involve significant risks and uncertainties. Actual results could differ materially from those anticipated in these forward looking statements as a result of a number of factors that will be included in the forthcoming financial statements. Forward looking information provided pursuant to the safe harbor established by recent securities legislation should be evaluated in the context of these factors.

SOURCE Megola, Inc.

 

RELATED LINKS